Open Market Through Stock Exchange | ₹60.00 Crores | Listing at BSE, NSE | Fri, Jul 15, 2022 - Sat, Jan 14, 2023
Marksans Pharma Ltd Buyback is a tender offer for the repurchase of up to equity shares at a buyback price of ₹60 per share with a face value of ₹1 per share, aggregating to ₹60.00 crores.
The buyback opens on Jul 15, 2022 and closes on Jan 14, 2023.
Sundae Capital Advisors Pvt.Ltd. is the Manager to the Buyback and Bigshare Services Pvt.Ltd. is the Registrar and Eureka Stock & Share Broking Services Limited is the Registered Broker to the Buyback.
Investors are advised to refer to the Marksans Pharma Ltd Letter of Offer for detailed information, including eligibility criteria, entitlement ratio, acceptance methodology, and tax implications.
Offer Opening Date
Fri, Jul 15, 2022
Offer Closing Date
Sat, Jan 14, 2023
Buyback Price
₹60 per share
Record Date
[.]
| Particulars | For the year/period ended (Rs. in Lakhs) | ||
|---|---|---|---|
| 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
| Total Income | 1,53,269.20 | 1,38,287.61 | 1,13,453.67 |
| Profit After Tax | 18,681.40 | 23,853.88 | 12,075.27 |
| Net Worth | 1,04,216.44 | 86,972.58 | 61,990.88 |
| Reserves and Surplus | 99,623.30 | 82,379.44 | 57,397.74 |
Marksans Pharma Ltd. is an Indian pharmaceutical company engaged in the research, manufacturing and marketing of finished dosage pharmaceutical formulations. The company employs the latest technology, automated manufacturing and packing operations and best practices, ensuring the highest quality of healthcare.
Marksans Pharma's manufacturing and R&D facility is located in Goa, India and in Southport, the UK for manufacturing non-sterile liquids, ointments and powder products.
The company has a footprint in the USA, Europe, South East Asia, Africa, Russia & CIS, Latin America and Australia.
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jun-2022 | 48.10 | 38.70 | 44.28 |
| May-2022 | 53.45 | 44.50 | 48.20 |
| Apr-2022 | 62.35 | 45.55 | 55.56 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jun-2022 | 48.10 | 38.60 | 44.15 |
| May-2022 | 53.50 | 44.50 | 48.23 |
| Apr-2022 | 62.40 | 45.50 | 56.03 |
The buyback is being undertaken for the following reasons:
1. The Buyback will help the Company to return surplus cash to its shareholders.
2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.
Marksans Pharma Ltd
11th Floor,
Veera Desai Extension Road,
Oshiwara, Andheri (W), Mumbai - 400 053
Andheri, Maharashtra, 400053
Lead Manager(s)
Registered Broker
The Marksans Pharma Buyback opens on July 15, 2022, and closes on January 14, 2023.
The Marksans Pharma Buyback is a Open Market Through Stock Exchange.
Marksans Pharma Buyback Schedule
| Buyback Opening Date | July 15, 2022 |
| Buyback Closing Date | January 14, 2023 |
| Last date for acceptance of shares | Upon relevant pay-out by the Stock exchange |
The Marksans Pharma Buyback is being offered at Rs ₹60 per share.
There is no ratio applicable in case of open market offer through stock exchange mechanism.
The Marksans Pharma Buyback has announced a buyback for an aggregate amount of not more than Rs. ₹60.00 Crores with pricing of Rs. ₹60 per share.
The buyback is being undertaken for the following reasons:
1. The Buyback will help the Company to return surplus cash to its shareholders.
2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.
Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.
The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.
The Marksans Pharma Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.
